-
EP3006463
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3006463
| EP3006463 - METHOD FOR STABILIZING ANTIBODY AND STABILIZED SOLUTION-TYPE ANTIBODY PREPARATION [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 08.06.2018 Database last updated on 08.04.2026 | Most recent event Tooltip | 16.10.2023 | New entry: Renewal fee paid | Applicant(s) | For all designated states Kyowa Kirin Co., Ltd. 1-9-2, Otemachi Chiyoda-ku Tokyo / JP | [2019/47] |
| Former [2016/15] | For all designated states Kyowa Hakko Kirin Co., Ltd. 1-6-1, Ohtemachi Chiyoda-ku Tokyo 100-8185 / JP | Inventor(s) | 01 /
Ueno, Yuji c/o Kyowa Hakko Kogyo Co., Ltd. Pharm. Res. Cter, 1188, Shimotogari Nagaizumi-cho, Sunto-gun Shizuoka, 411-8731 / JP | 02 /
Kayashita, Takashi c/o Kyowa Hakko Kogyo Co., Ltd. Pharm. Res. Cter, 1188, Shimotogari Nagaizumi-cho, Sunto-gun Shizuoka, 411-8731 / JP | 03 /
Ishihara, Atsushi c/o Kyowa Hakko Kogyo Co., Ltd. Pharm. Res. Cter, 1188, Shimotogari Nagaizumi-cho, Sunto-gun Shizuoka, 411-8731 / JP | 04 /
Nakakura, Masashi c/o Kyowa Hakko Kogyo Co., Ltd. Pharm. Res. Cter, 1188, Shimotogari Nagaizumi-cho, Sunto-gun Shizuoka, 411-8731 / JP | 05 /
Yamauchi, Kyoko c/o Kyowa Hakko Kogyo Co., Ltd. Pharm. Res. Cter, 1188, Shimotogari Nagaizumi-cho, Sunto-gun Shizuoka, 411-8731 / JP | [2016/15] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2016/15] | Application number, filing date | 15191413.2 | 01.10.2004 | [2016/15] | Priority number, date | JP20030343645 | 01.10.2003 Original published format: JP 2003343645 | [2016/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3006463 | Date: | 13.04.2016 | Language: | EN | [2016/15] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 10.03.2016 | Classification | IPC: | C07K16/00, C07K16/46, A61K39/395, A61K9/08, A61K47/12, A61K47/18, A61K9/00, C07K16/18, C07K16/28 | [2016/15] | CPC: |
A61K9/0019 (EP,US);
C07K16/46 (KR);
A61K39/39591 (EP,US);
A61K47/12 (EP,US);
A61K47/183 (EP,US);
A61K9/08 (KR);
C07K16/00 (KR);
C07K16/18 (US);
C07K16/2866 (US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2016/15] | Title | German: | VERFAHREN ZUR STABILISIERUNG VON ANTIKÖRPERN UND STABILISIERTE ANTIKÖRPERZUBEREITUNG VOM LÖSUNGSTYP | [2016/15] | English: | METHOD FOR STABILIZING ANTIBODY AND STABILIZED SOLUTION-TYPE ANTIBODY PREPARATION | [2016/15] | French: | PROCÉDÉ DE STABILISATION D'ANTICORPS ET PRÉPARATION D'ANTICORPS DE TYPE SOLUTION STABILISÉE | [2016/15] | Examination procedure | 26.10.2015 | Examination requested [2016/15] | 04.10.2016 | Amendment by applicant (claims and/or description) | 06.06.2018 | Despatch of a communication from the examining division (Time limit: M04) | 08.10.2018 | Reply to a communication from the examining division | 07.02.2019 | Despatch of a communication from the examining division (Time limit: M04) | 07.06.2019 | Reply to a communication from the examining division | 08.05.2020 | Despatch of a communication from the examining division (Time limit: M04) | 15.09.2020 | Reply to a communication from the examining division | Parent application(s) Tooltip | EP04773700.2 / EP1698640 | Fees paid | Renewal fee | 26.10.2015 | Renewal fee patent year 03 | 26.10.2015 | Renewal fee patent year 04 | 26.10.2015 | Renewal fee patent year 05 | 26.10.2015 | Renewal fee patent year 06 | 26.10.2015 | Renewal fee patent year 07 | 26.10.2015 | Renewal fee patent year 08 | 26.10.2015 | Renewal fee patent year 09 | 26.10.2015 | Renewal fee patent year 10 | 26.10.2015 | Renewal fee patent year 11 | 26.10.2015 | Renewal fee patent year 12 | 27.10.2016 | Renewal fee patent year 13 | 24.10.2017 | Renewal fee patent year 14 | 26.10.2018 | Renewal fee patent year 15 | 16.10.2019 | Renewal fee patent year 16 | 19.10.2020 | Renewal fee patent year 17 | 18.10.2021 | Renewal fee patent year 18 | 18.10.2022 | Renewal fee patent year 19 | 16.10.2023 | Renewal fee patent year 20 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY] EP1314437 (CHUGAI PHARMACEUTICAL CO LTD et al.) | [XY] EP1254666 (CHUGAI PHARMACEUTICAL CO LTD et al.) | [XY] EP0597101 (HAGIWARA HIDEAKI et al.) | [XY] US4721777 (UEMURA YAHIRO et al.) | [XY] WO9322335 (COR THERAPEUTICS INC et al.) | [Y] FR2708467 (PASTEUR MERIEUX SERUMS VACC et al.) | [XY] WO9937329 (ASTRA AB et al.) | [Y] WO0066160 (YAMANOUCHI PHARMA CO LTD et al.) | [Y] WO0067791 (APPLIED RESEARCH SYSTEMS et al.) | [X] JPH01143835 (BIOTEST AG et al.) | [Y] CHEN B L: "Strategies to suppress aggregation of recombinant keratinocyte growth factor during liquid formulation development", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION, WASHINGTON, US, vol. 83, no. 12, 1 December 1994 (1994-12-01), pages 1657 - 1661, XP002075996, ISSN: 0022-3549, DOI: 10.1002/JPS.2600831204 DOI: http://dx.doi.org/10.1002/jps.2600831204 | [Y] KANAZAWA JUNJI ET AL: "Therapeutic potential of chimeric anti-(ganglioside GD3) antibody KM871: Antitumor activity in xenograft model of melanoma and effector function analysis", CANCER IMMUNOLOGY IMMUNOTHERAPY, vol. 49, no. 4-5, July 2000 (2000-07-01), pages 253 - 258, XP002491343, ISSN: 0340-7004 DOI: http://dx.doi.org/10.1007/s002620000101 | [XY] WEVERS R A ET AL: "An immunobioluminescence assay for gamma-gamma enolase activity in human serum and cerebrospinal fluid", CLINICA CHIMICA ACTA, ELSEVIER BV, AMSTERDAM, NL, vol. 178, no. 2, 15 December 1988 (1988-12-15), pages 141 - 150, XP023396055, ISSN: 0009-8981, [retrieved on 19881215], DOI: 10.1016/0009-8981(88)90220-3 [Y] 1-25 DOI: http://dx.doi.org/10.1016/0009-8981(88)90220-3 | Examination | US5945098 | MEHTA DEEPAK: "Formulation and stability of murine and CDR-grafted anti-tissue factor monoclonal antibody", PHARMACEUTICAL RESEARCH, 1 October 1994 (1994-10-01), pages S - 73, XP055478753 | by applicant | JPH10502938 | WO0213860 | JPH03504499 | JP3006943 | JPH05304989 | WO0123432 | WO0164754 | WO03018635 | JOURNAL OF PHARMACEUTICAL SCIENCE, vol. 83, no. 12, 1994, pages 1657 - 1661 | PHARMACEUTICAL RESEARCH, vol. 11, no. 5, 1994, pages 624 - 632 | BIOCHEMISTRY, vol. 38, 1999, pages 13960 - 13967 | REITER ET AL., PROTEIN ENGINEERING, vol. 7, 1994, pages 697 - 704 |